Fineline Cube

Follow:
14404 Articles
Boehringer Ingelheim Partners with Broad Institute for Mental Health Treatments
CompanyDeals

Boehringer Ingelheim Partners with Broad Institute for Mental Health Treatments

HuidaGene Receives FDA Clinical Clearance for HG202 in Neovascular AMD Treatment
CompanyDrug

HuidaGene Receives FDA Clinical Clearance for HG202 in Neovascular AMD Treatment

NMPA Grants Marketing License to Abonisi Medical Technology's Knee Joint Prosthesis System
CompanyMedical Device

NMPA Grants Marketing License to Abonisi Medical Technology’s Knee Joint Prosthesis System

Isap Biotech Secures FDA IND Approval for iSAP-0909 for Bladder Cancer Imaging
CompanyDrug

Isap Biotech Secures FDA IND Approval for iSAP-0909 for Bladder Cancer Imaging

China Grand Pharmaceutical Completes Phase III Clinical Study for Post-Cataract Surgery Treatment
CompanyDrug

China Grand Pharmaceutical Completes Phase III Clinical Study for Post-Cataract Surgery Treatment

111 Inc. Appoints Yang "Luke" Chen to Board of Directors Following Resignation of Dr. Lian Yong Chen
CompanyDigital

111 Inc. Appoints Yang “Luke” Chen to Board of Directors Following Resignation of Dr. Lian Yong Chen

Shanghai RMX Biopharma and PharmaEngine Ink Distribution Deal for Liporaxel in Taiwan
CompanyDeals

Shanghai RMX Biopharma and PharmaEngine Ink Distribution Deal for Liporaxel in Taiwan

China's National Allied Procurement Office Launches 10th VBP Tender Round Information Filing
Policy / Regulatory

China’s National Allied Procurement Office Launches 10th VBP Tender Round Information Filing

NMPA Releases 84th Batch of Reference Drugs for GQCE and First Batch Stripped of Status
Policy / Regulatory

NMPA Releases 84th Batch of Reference Drugs for GQCE and First Batch Stripped of Status

J&J MedTech Completes Pilot Enrollment for OMNY-AF Study on Atrial Fibrillation Treatment
CompanyMedical Device

J&J MedTech Completes Pilot Enrollment for OMNY-AF Study on Atrial Fibrillation Treatment

Innorna Co., Ltd Receives FDA Rare Pediatric Disease Designation for mRNA Drug IN015
CompanyDrug

Innorna Co., Ltd Receives FDA Rare Pediatric Disease Designation for mRNA Drug IN015

Teva Pharmaceutical Reports Positive Phase III Results for TEV-'749 in Schizophrenia Trial
CompanyDrug

Teva Pharmaceutical Reports Positive Phase III Results for TEV-‘749 in Schizophrenia Trial